Dena Dahlquist
Family · Bradenton, FLNPI 1316257017
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 158 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 21.1% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2021 at $1,173 and has fallen 94.1% since, to $69 in 2025.
Across 158 payments — averaging $19.11 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$638
- AbbVie$339
- Lilly USA, LLC$310
- Exact Sciences$200
- Biohaven Pharmaceutical Holding Company Ltd.$165
- GSK$158
- plus $1K from 21 others
What the payments were for
- Food & beverage$3,020100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 32 | $638 |
| AbbVie | 18 | $339 |
| Lilly USA, LLC | 19 | $310 |
| Exact Sciences | 7 | $200 |
| Biohaven Pharmaceutical Holding Company Ltd. | 7 | $165 |
| GSK | 8 | $158 |
| Pfizer | 8 | $156 |
| Johnson & Johnson | 8 | $150 |
| Novartis | 5 | $93 |
| Biohaven Pharmaceuticals, Inc. | 6 | $93 |
| Eisai Inc. | 5 | $89 |
| Bayer | 4 | $85 |
| Boehringer Ingelheim | 5 | $84 |
| Biogen | 3 | $69 |
| Astellas Pharma US Inc | 4 | $63 |
| Amgen | 4 | $62 |
| Hologic Sales And Service, LLC | 2 | $44 |
| Merck | 2 | $39 |
| Esperion Therapeutics, Inc. | 2 | $35 |
| AstraZeneca | 2 | $24 |
| Ultragenyx Pharmaceutical Inc. | 1 | $23 |
| Abbott | 1 | $19 |
| Idorsia Pharmaceuticals US Inc | 1 | $19 |
| Boston Scientific | 1 | $18 |
| Phadia US Inc. | 1 | $17 |
| Ardelyx, Inc. | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $13 |
How this compares
$3,020 in reported general payments places this provider in the 85th percentile of 14,618 family providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 23 | $43,410 |
| EliquisApixaban | 13 | $20,167 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 18 | $17,424 |
| JardianceEmpagliflozin | 12 | $8,219 |
| Levothyroxine Sodium | 140 | $1,298 |
| Estradiol | 21 | $1,251 |
| SynthroidLevothyroxine Sodium | 11 | $922 |
| Lisinopril | 128 | $806 |
| Atorvastatin Calcium | 95 | $753 |
| Escitalopram Oxalate | 45 | $722 |
| Omeprazole | 34 | $674 |
| Trazodone Hcl | 16 | $501 |
| Zolpidem Tartrate | 32 | $486 |
| Fluoxetine Hcl | 36 | $462 |
| Duloxetine Hcl | 14 | $449 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $638 | $43,41023 claims |
| PfizerEliquis | $156 | $20,16713 claims |
| GSKTrelegy Ellipta | $158 | $17,42418 claims |
| Boehringer IngelheimJardiance | $84 | $8,21912 claims |
| AbbVieSynthroid | $339 | $92211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 14,618 family providers in Florida.
Other family in Bradenton
- Lewis HarringtonTampa$954K
- Danielle PharesFt Lauderdale$713K
- Donna OrtizOrlando$417K
- Patrick SzarazMiami$327K
- Deena RodneyMaitland$323K
- Yamila MelendezMiami$212K
- Holly BoydLand O Lakes$200K
- Rachael BuschLoxahatchee$189K
- Victor Tatis de la NuezMiramar$161K
- Ronda CrewsJax Bch$155K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.